IdentificationofaMutantKinase/ATPAnalogPair |
|
ScottT.Eblen,N.VinayKumar,andMichaelJ.WeberDepartmentofMicroBIOLOGyandCancerCenter,UniversityofVirginiaHealthSystem,Charlottesville,VA22908ExcerptedfromProtein:ProteinInteractions,SecondEditionEditedbyEricaA.GolemisandPeterD.Adams |
ABSTRACT |
ProteinKinasecascadesregulatemanyaspectsofcellularbiochemistryandphysiology.Determiningthedirectsubstratesofproteinkinasesisimportantinunderstandinghowthesesignalingenzymesexerttheireffectsoncellularprocesses.ArecentdevelopmentinthisareatakesadvantageofthesimilarityintheATP-bindingdomainsofproteinkinases.ConservedresiduesintheATP-bindingsitecontainlargesidechainsthatcomeintoclosecontactwiththeN6positionofboundATP.Mutationofoneormoreoftheselargeresiduestoalanineorglycinegeneratesa"pocket"intheATP-bindingsitethatallowsthemutantkinase,butnotthewild-typekinaseorothercellularkinases,toutilizeanalogsofATPwithbulkysubstituentssynthesizedontotheN6position.KinasereactionsperformedwithamutatedkinaseandrADIolabeledATPanalogsinacellularlysateallowspecificlabelingofdirectsubstratesofthemutantkinase,whichcanlaterbeidentifiedbymassspectrometryorothermeans.Oncepocketmutationshavebeengeneratedinthekinase,itisnecessarytoscreenATPanalogsfortheircompatibilitywiththekinasemutant.Thissteprequiresanactiveformofthewild-typeandmutantkinase,eitherasrecombinantactivatedprotein,orasproteinthathasbeenimmunoprecipitatedfromtransfected,stimulatedcells.Inaddition,aknowninvitrosubstrateforthekinaseisalsorequired.ScreeningthemutantkinaseswithATPanalogsisbestperformedinatwo-stepprocess.ThefirststepinvolvesassayingtheABIlityofanATPanalogtoinhibittheincorporationofradioactivephosphatefromnormal[y-32P]ATPintoaknownsubstrateinaninvitrokinasereaction.ThismethodallowsalargenumberofATPanalogstobescreenedeasily,withouttheneedforcreatingnumerousradiolabeledATPanalogs,savingtimeandbypassingtheneedforunnecessaryradioactivework.Moreover,quantitativecompetitionstudiescanbeperformedtoidentifyanalog-mutantpairswithhighaffinity.ItisimportanttokeepinmindthattherearetworeasonsanATPanalogcaninhibitincorporationoflabeledphosphateintosubstrate.ThefirstisthattheATPanalogisagoodATPsourceforusebythekinaseandcompeteswiththe[y-32P]ATPasasubstrate.ThesecondisthattheATPanalogissmallenoughtointeractwiththeATP-bindingsiteofthekinasebutisunabletobeusedbythekinaseasanATPsourceandisthereforesimplyblocking[y-32P]ATPfromtheATP-bindingsite.Todistinguishbetweenthese,itisnecessarytodirectlytesttheabilityofthemutantkinasetophosphorylateasubstratewithanalogATP.DoingthisrequireseitherradiolabeledATPanalogsor,preferably,aphospho-specificantibodytothephosphorylationsiteontheknownsubstrate.Inourexperiments,weusedacommerciallyavailablephospho-specificantibodytotheERK2substrateElk1.Aphospho-specificantibodyallowsalargenumberofATPanalogstobescreenedwithouttheirhavingtobemaderadioactive.Inthisassay,activewild-typeormutantkinaseismixedwithATPanalogandsubstrateinaninvitrokinasereaction.Thereactionisthenanalyzedbysodiumdodecylsulfate-polyacrylamidegelelectrophoresis(SDS-PAGE),transferredtonitrocellulose,andeitherstainedwithPonceauSandcountedbyCerenkovcounting(if[y-32P]ATPanalogisused)orimmunoblottedwithaphosphospecificantibody(ifavailable)todeterminetheextentofsubstratephosphorylation.Thekinase/ATPanalogpairthatprovidesthebestphosphorylationofthesubstrateisthenusedforfutureexperiments.Onlythoseanalogsthatcannotbeusedbythewild-typekinaseandothercellularkinasesarechosen. |
|
MATERIALS |
Buffers,Solutions,andReagents |
- M2Lysisbuffer(cold)[II],freshlyprepared
- 50mMTris-base(pH7.4)
- 150mMNaCl
- 10%glycerol
- 1%TritonX-100
- 0.5mMEDTA
- 0.5mMEGTA
- 50mMNaF
- 40mMβ-glycerophosphate
- 5mMtetrasodiumpyrophosphate
- 0.1mMsodiumvanadate
- 10µg/mlaprotinin
- 5µg/mlleupeptin
- 2mMphenylmethylsulfonylfluoride(PMSF),fresh
- Aceticacid(1%)
- 10xKinasebuffer
- 250mMHEPES(pH7.4)
- 100mMmagnesiumacetate
- 10mMdithiothreitol(DTT)
- KinasereactionbufferA(fortheanaloginhibitionassay)
- 1xkinasebuffer
- 10µMATP
- 100µMATPanalog
- 10µCi/reaction[y-32P]ATP
- 1-5µgofaknownsubstrate/reaction
- KinasereactionbufferB(forthesubstratephosphorylationassay)
- 1xkinasebuffer
- 100µMATPanalog
- 1-5µgofaknownsubstrate/reaction
- 10µCi/reaction[y-32P]ATPanalog(requiredonlyifaphospho-specificantibodytothesubstrateisnotavailable)
- 1xPBS(cold)[I]
- 25.6gofNa2HPO4˙7H2O
- 80gofNaCl
- 2gofKCl
- 2gofKH2PO4
- Bringto1literwithdistilled,deionizedwater;autoclavefor40minat121°C.
- PonceauSsolution
- 0.5%(w/v)in1%aceticacid
- 2xLaemmlisamplebuffer
- 100mMTris(pH6.8)
- 2%SDS
- 20%glycerol
- 4%β-mercaptoethanol(addedfresh)
- Dulbecco"smodifiedEaglemedium(DMEM)
- Fetalbovineserum(FBS)
|
CellsandAntibodies |
- COS-1Africangreenmonkeykidneyepithelialcells(ATCC)
- Antibodiestotheepitopetagontheproteinkinaseofinterest
- Aphospho-specificantibodytoaknownsubstrateofyourkinase(ifavailable)
|
Gels |
|
SpecialEquipment |
- Microcentrifugewithcoolingfacility
- Transfertankforwesternblotting
- 30°Cwaterbath
- Scintillationcounter
- Heatingblock,presetto100°C(I)
|
AdditionalReagents |
- [y-32P]ATP(6000Ci/mmole)
- AgoNIST(I);e.g.,epidermalgrowthfactor,serum,platelet-derivedgrowthfactorLipofectamine
- M2agarose(forFLAG-taggedproteinkinases)
- ProteinA-orproteinG-conjugatedagaroseorSepharoseCL-6beads(forpreparationofantibody,seestep7)
- BCAproteinassaykit
- Hypodermicneedle1",27gauge
- Syringe,1cc
- Nitrocellulosemembrane
- Vacuumflask
- Shaker,presetto4°C
- Incubator,presetto37°C[I]
- 60-mmtissueculturedishes[I]
|
Plasmids |
- Expressionplasmidofchoice
|
|
METHOD |
CellularTransfectionandImmunoprecipitationBeforeproceedingwiththeexperimentsoutlinedbelow,allkinasepocketmutantsshouldbecharacterizedfortheirexpression,localization,specificactivity,andsubstratespecificity.Theresultsshouldbecomparedwiththoseobtainedfromthewild-typekinasetoensurethatthemutationdoesnotsignificantlyalterthesecharacteristics.- GrowCOS-1cellsinDMEMsupplementedwith10%FBS.Platecellsthedaybeforetransfectionat4x105cellsperdishin60-mmtissueculturedishes.Incubateat37°Cand5%CO2overnight.
- Transfectcellswith2µgofexpressionplasmidusingLipofectamine,accordingtothemanufacturer"sspecifications.Wehavefoundthata1:4ratioofDNAtoLipofectamineisoptimalfortransfectionofCOS-1cells.
- Incubatethecellsfor24-72hoursat37°Cand5%CO2.Therestofstep3andstep4areoptionalandcanbevarieddependingonthekinaseofinterest.Formitogen-activatedkinases,serum-starvetransfectedcellsbywashingtwicewithroom-temperaturephosphate-bufferedsaline(PBS)andplacinginserum-freemediafor4-12hrpriortoharvest.
- Stimulatethecellsfor10minbeforeharvestwithanagonistthatactivatesthekinaseofinterest.Harvestthecellsat24-72hrposttransfection.
- WashthecellstwiceincoldPBSonice.Drainthedisheswell.Add0.5mlofM2lysisbufferandscrapeeachdishofcellsintomicrocentrifugetubes.Vortex.Letthecellslyseonicefor15min,vortexingoccasionally.Centrifugeat15,000gand4°Cinamicrocentrifugefor15min.Transferthesupernatanttoafreshtube.
- PerformaproteinassayonthecelllysatesusingaBCAassaykitfromPierce.Wetypicallyobtain0.5mgofproteinper6-cmdish.
- Preparetheantibodyfortheimmunoprecipitation(HarlowandLane1999).WeuseM2agaroseforFLAG-taggedERKs.Iftheantibodytotheepitopetagontheproteinisnotpreconjugated,prebindtheprimaryantibodyforyourepitopetagtoproteinA-orproteinG-conjugatedagaroseorSepharoseCL-6beads.Ifnecessary,useasecondaryantibodytolinktheprimaryantibodytothebeads(HarlowandLane1999).Theamountofantibodytousewillbeantibody-andprotein-specific.Forthesmall-scaleimmunoprecipitationsdescribedinstep8,0.1µgofantibodyperimmunoprecipitationshouldbesufficient.Batchprebindingcanbeperformedwithenoughantibodyandconjugatedbeadsforallofyourreactions.Prebindingshouldbeperformedin1mlofM2celllysisbufferfor1hrat4°Cwithconstantagitation.AdditionalunconjugatedSepharoseCL-6beadscanbeincludedintheprebindingtoincreasethebeadvolumeforeachkinasereaction.Wefindthatatotalof30µlofbeadvolumeisoptimalforeachreaction.Afterprebinding,centrifugetheantibodymixtureat15,000ginamicrofugefor30sec.AspiratethesupernatantandwashthebeadstwiceinM2lysisbuffertoremoveunboundantibody.Aspiratethewashbuffer.ResUSPendthebeadsinanequalvolumeofM2lysisbuffertomakea1:1bead:bufferslurry.
- Aliquot50µgofcellularprotein(asdeterminedinstep6)intofreshmicrocentrifugetubes,usingonetubeforeachreaction(usemoreorlessprotein,dependingontheabundanceandactivityofyourkinase).Wetypicallyperformkinasereactionsinduplicatetocontrolforvariabilityintheassay.AddM2lysisbuffertoatotalvolumeof750µl.
- Aliquotthepreconjugatedantibody(60µlof1:1bead:bufferslurryfromstep7)intoeachofthetubescontainingcelllysate.Incubateat4°Cfor2hrwithgentlerocking.
- Centrifugethesamplesat15,000gat4°Cfor30sec.Aspiratethesupernatant.Washthebeadsthreetimeswith1mlofcoldM2lysisbuffer,followedbytwowasheswith1xkinasebuffer.Aspiratethefinalwashbufferdowntothebeads.Keepthesamplesonice.
- Justbeforestartingthekinasereaction,aspiratetheresidualkinasebufferwitha27gaugeneedleattachedtoa1-ccsyringeandavacuumflask.Keepthebeveledsideoftheneedlefacingthewallofthetubetopreventaspiratinganybeads.Usethisimmunoprecipitatedproteinfortheanaloginhibitionassayandthesubstratephosphorylationassay.
- Analoginhibitionassayandsubstratephosphorylationassay:2x50-µgaliquotsofcellularproteinarerequiredfortheanaloginhibitionassayandafurther2x50µgarerequiredforsubstratephosphorylation.
- Add40µlofkinasereactionmixturetoeachtubeonice.(Note:KinasereactionmixtureAisforanaloginhibitionassays.KinasereactionmixtureBisforthesubstratephosphorylationassay.)Mixgentlybyflickingthetubewithyourfinger.
- Incubatesamplesina30°Cwaterbathfor10min.Placethesamplesoniceandimmediatelyadd40µlof2xLaemmlisamplebuffertostopthereaction.Vortexthesamples.
- Heatthesamplesfor4mininaboilingwaterbathorheatingblock.Centrifugethesamplesat15,000gatroomtemperaturefor30sec.
- LoadthesupernatantonanSDS-polyacrylamidegelandelectrophorese.
- Transferthegeltonitrocellulosemembrane.
- Placethemembraneinaglassdish.Stainthemembranefor5minwithPonceauSsolution.Removethestainanddestainthemembranetwice,for5mineach,with1%aceticacid.
- If[y-32P]ATPor[y-32P]ATPanalogisused,cutthesubstratebandsoutofthegelandcountthemindividuallybydryCerenkovcountingonascintillationcounter.Ifaphospho-specificantibodytothesubstrateisavailable,leavetheblotintactandimmunoblotwiththeantibody(HarlowandLane1999).
- Fortheanaloginhibitionassay,calculatethepercentageoflabeledphosphorylationfromeachreaction.Thecpmfromduplicateassaysshouldbeaveraged,andthevalueobtainedfromthekinasereactionsthatdidnotcontainATPanalogshouldbesetto100%.Thencomparetheaveragecountsfromtheotherkinasereactionstothoseofthecontrolreactionandexpresstheratioasapercentage.
- Forthesubstratephosphorylationassay,usethemutantkinase/ATPanalogpairthatgivesthehighestphosphorylation,eitherthroughimmunoblottingorradioactivemeasurements,forfuturestudies.
|
REFERENCES |
HarlowE.H.andLaneD.L.1999.UsingAntibodies:ALaboratoryManual.ColdSpringHarborLaboratoryPress,ColdSpringHarbor,NewYork. |
免责声明 本文仅代表作者个人观点,与本网无关。其创作性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
版权声明 未经蚂蚁淘授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的,应该授权范围内使用,并注明“来源:蚂蚁淘”。违反上述声明者,本网将追究其相关法律责任。